I meant to add in my previous post that IMO AHZ needs a big brother to really push Cardiocel. I still think it's a big ask for AHZ to go it alone in the face of big US pharma. They are scum and will bribe their way to the front regardless of the superiority a competitor's product. Maybe a partnership would impact what AHZ could achieve if it were successful by going it alone but hell, market domination would eventually win out if it were to get into bed with one of those big whoring US pharmas.
just my opinion.
Ann: Admedus Receives FDA Clearance for CardioCel 3D, page-52
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |